Amylyx Pharmaceuticals (AMLX) Tax Provisions (2022 - 2025)
Amylyx Pharmaceuticals (AMLX) posted quarterly Tax Provisions of $46000.0 for Q4 2025, up 100.07% year-over-year from $22991.7 in Q4 2024, and up 100.07% quarter-over-quarter from -$63.7 million in Q4 2024.
Amylyx Pharmaceuticals (AMLX) Tax Provisions (2022 - 2025) Analysis & Trends
Amylyx Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $46000.0 for Q4 2025.
- In Q4 2025, Tax Provisions rose 100.07% year-over-year to $46000.0; the TTM figure through Dec 2025 stood at $46000.0 (up 100.07% YoY), while the FY2025 annual figure was $46000.0, up 100.07% from the prior year.
- Tax Provisions for Q4 2025 stood at $46000.0, up from -$63.7 million in the prior quarter.
- The five-year high for Tax Provisions was $1.9 million in Q2 2023, with the low at -$63.7 million in Q4 2024.
- The 4-year median for Tax Provisions is $200000.0 (2022), against an average of -$5.2 million.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions jumped 1314.4% in 2023, then slumped 3749.91% in 2024.
- Amylyx Pharmaceuticals' Tax Provisions stood at $579000.0 in 2022, then soared by 201.38% to $1.7 million in 2023, then plunged by 3749.91% to -$63.7 million in 2024, then surged by 100.07% to $46000.0 in 2025.
- Business Quant data shows AMLX's Tax Provisions at $46000.0 in Q4 2025, -$63.7 million in Q4 2024, and $242000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 175.00 Mn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 18.30 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 2.00 Mn |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46,000.00 |
| Dec 31, 2024 | -63.69 Mn |
| Mar 31, 2024 | 242,000.00 |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | -170,000.00 |
| Dec 31, 2022 | 579,000.00 |
| Sep 30, 2022 | -125,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 146,000.00 |